|
2024
|
Invention
|
Treatment of idiopathic pulmonary fibrosis.
According to the invention there is provided a metho... |
|
|
Invention
|
Selective angiotensin ii compounds.
There is provided pharmaceutical compounds of formula I,
T... |
|
|
Invention
|
New delayed release composition for peroral administration.
According to the invention there is ... |
|
|
Invention
|
Selective angiotensin ii compounds. There is provided pharmaceutical compounds of formula (I), wh... |
|
2023
|
Invention
|
A method of treating a patient diagnosed with an interstitial lung disease. Aspects of the presen... |
|
|
Invention
|
Treatment of idiopathic pulmonary fibrosis. According to the invention there is provided a method... |
|
|
Invention
|
New dry powder composition for peroral administration.
There is provided a pharmaceutical dosage... |
|
|
Invention
|
Method of treating a patient diagnosed with an interstitial lung disease.
Aspects of the present... |
|
|
Invention
|
Delayed release composition for peroral administration. According to the invention there is provi... |
|
|
Invention
|
Use of buloxibutid for the treatment of idiopathic pulmonary fibrosis. According to the invention... |
|
2022
|
G/S
|
Downloadable computer software with medical information and content for facilitating the provisio... |
|
|
Invention
|
New selective angiotensin ii compounds.
There is provided pharmaceutical compounds of formula I,... |
|
|
Invention
|
New selective angiotensin ii compounds. There is provided pharmaceutical compounds of formula I, ... |
|
|
Invention
|
Selective angiotensin ii receptor ligands.
There is provided pharmaceutical compounds of formula... |
|
|
Invention
|
Selective angiotensin ii receptor ligands. There is provided pharmaceutical compounds of formula ... |
|
|
Invention
|
Dry powder composition for peroral administration. There is provided a pharmaceutical dosage form... |
|
|
G/S
|
Pharmaceuticals and medical preparations for human use; Pharmaceutical preparations within the fi... |
|
|
Invention
|
Use of angiotensin ii type 2 receptor agonist.
There is provided N-butyloxycarbonyl-3-(4-imidazo... |
|
2021
|
G/S
|
Pharmaceuticals and medical preparations for human use, namely, prescription drugs, namely, pills... |
|
|
G/S
|
Pharmaceuticals and medical preparations for human use;
pharmaceutical preparations within the f... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of ophthalmological diseases and disorders; pharmac... |
|
|
Invention
|
Novel compounds for use in the treatment of diseases associated with angiotensin ii.
T... |
|
|
Invention
|
Novel compounds for use in the treatment of diseases associated with angiotensin ii. There is pro... |
|
|
Invention
|
New use of angiotensin ii type 2 receptor agonist.
There is provided N-butyloxycarbonyl-3-(4-imi... |
|
|
Invention
|
New injectable formulations comprising immunomodulator drug. According to the invention, there is... |
|
|
Invention
|
Process for the synthesis of n-butyloxycarbonyl-3-(4-imidazol-1-
ylmethylphenyl)-5-iso-butylthiop... |
|
|
Invention
|
Process for the synthesis of n-butyloxycarbonyl-3-(4-imidazol-1-ylmethylphenyl)-5-iso-butylthioph... |
|
|
Invention
|
New capsule composition for peroral administration.
According to the invention there is provided... |
|
|
Invention
|
New capsule composition for peroral administration. According to the invention there is provided ... |
|
|
Invention
|
New delayed release composition for peroral administration. According to the Invention there is p... |
|
|
Invention
|
New dry powder composition for peroral administration. According to the invention there is provid... |
|
|
Invention
|
New use of angiotensin ii type 2 receptor agonist. There is provided N-butyloxycarbonyl-3-(4-imid... |
|
|
Invention
|
Novel compounds useful in the treatment and/or prevention of a disease, disorder or condition ass... |
|
|
Invention
|
Imidazolyl thiopehene sulfonyl carbamates for use in the treatment of diseases associated with an... |
|
2020
|
Invention
|
Use of angiotensin ii type 2 receptor agonist. There is provided N-butyloxycarbonyl-3-(4-imidazol... |
|
|
Invention
|
New use of angiotensin ii receptor agonist. There is provided N-butyloxycarbonyl-3-(4-imidazol-1-... |
|
|
Invention
|
New compositions. According to the invention, there is provided a pharmaceutical composition suit... |
|
|
Invention
|
New compounds.
There is provided herein a compound of formula I, wherein R1, R2, R3 Y1, Y2, Y3, ... |
|
|
Invention
|
New compounds. There is provided herein a compound of formula I, wherein R1, R2, R3Y1, Y2, Y3, Y4... |
|
|
G/S
|
Pharmaceutical preparations within the fields of pulmonary diseases, cardiovascular diseases, aut... |
|
2019
|
Invention
|
New composition comprising amorphous nanoporous silica particles.
According to the invention, th... |
|
|
Invention
|
New composition comprising amorphous nanoporous silica particles. According to the invention, the... |
